ADAR1 and ADAR2 expression and editing activity during forebrain development

Developmental Neuroscience

Volumn 31, Issue 3, 2009, Pages 223-237

  Jacobs, Michelle M ^a,b   Fogg, Rachel L ^c   Emeson, Ronald B ^a,b,c   Stanwood, Gregg D ^b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

ADAR; Adenosine; Inosine; Mouse; Neuron; Prenatal development; Serotonin

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DEAMINASE 1; ADENOSINE DEAMINASE 2; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN REGION; CONTROLLED STUDY; DIENCEPHALON; EMBRYO; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; FOREBRAIN; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FAMILY; RNA EDITING;

ADENOSINE DEAMINASE; ANIMALS; EMBRYO, MAMMALIAN; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEUROGENESIS; PROSENCEPHALON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA EDITING; RNA, MESSENGER;

EID: 67649130153     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210185     Document Type: Article

References (54)

1. Gott JM, Emeson RB: Functions and mechanisms of RNA editing. Annu Rev Genet 2000; 34: 499-531.
2. Bass BL, Nishikura K, Keller W, Seeburg PH, Emeson RB, O'Connell MA, Samuel CE, Herbert A: A standardized nomenclature for adenosine deaminases that act on RNA. RNA 1997; 3: 947-949.
3. Bass BL: RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 2002; 71: 817-846.
4. Hough RF, Bass BL: Purification of the Xenopus laevisdouble- stranded RNA adenosine deaminase. J Biol Chem 1994; 269: 9933- 9939.
5. Kim KS, Teixeira SM, Kirchhoff LV, Donelson JE: Transcription and editing of cytochrome oxidase II RNAs in Trypanosoma cruzi.J Biol Chem 1994; 269: 1206-1211.
6. Kim U, Garner TL, Sanford T, Speicher D, Murray JM, Nishikura K: Purification and characterization of double- stranded RNA adenosine deaminase from bovine nuclear extracts. J Biol Chem 1994; 269: 13480- 13489.
7. Maas S, Melcher T, Herb A, Seeburg PH, Keller W, Krause S, Higuchi M, O'Connell MA: Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase. J Biol Chem 1996; 271: 12221- 12226.
8. O'Connell MA, Keller W: Purification and properties of double-stranded RNA-specific adenosine deaminase from calf thymus. Proc Natl Acad Sci USA 1994; 91: 10596- 10600.
9. O'Connell MA, Krause S, Higuchi M, Hsuan JJ, Totty NF, Jenny A, Keller W: Cloning of cDNAs encoding mammalian doublestranded RNA-specific adenosine deaminase. Mol Cell Biol 1995; 15: 1389-1397.
10. Rueter S, Emeson R: Adenosine-to-inosine conversion in mRNA; in Grosjean H, Benne R (eds): Modification and Editing of RNA. Washington, ASM Press, 1998, pp 343-361.
11. Rueter SM, Dawson TR, Emeson RB: Regulation of alternative splicing by RNA editing. Nature 1999; 399: 75- 80.
12. Bhalla T, Rosenthal JJ, Holmgren M, Reenan R: Control of human potassium channel inactivation by editing of a small mRNA hairpin. Nature Struct Mol Biol 2004; 11: 950- 956.
13. A receptor function by RNA editing. J Neurosci 2008; 28: 6196- 6201.
14. Sommer B, Kohler M, Sprengel R, Seeburg PH: RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 1991; 67: 11-19.
15. 2+ permeability in both TM1 and TM2 of high affinity kainite receptor channels: diversity by RNA editing. Neuron 1993; 10: 491-500.
16. Sailer A, Swanson GT, Perez-Otano I, O'Leary L, Malkmus SA, Dyck RH, Dickinson- Anson H, Schiffer HH, Maron C, Yaksh TL, Gage FH, O'Gorman S, Heinemann SF: Generation and analysis of GluR5(Q636R) kainate receptor mutant mice. J Neurosci 1999; 19: 8757-8764.
17. 2+ permeability of unedited and edited versions of the kainite selective glutamate receptor GluR6. Proc Natl Acad Sci USA 1993; 90: 755-759.
18. Lomeli H, Mosbacher J, Melcher T, Hoger T, Geiger JR, Kuner T, Monyer H, Higuchi M, Bach A, Seeburg PH: Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 1994; 266: 1709-1713.
19. Niswender C, Copeland S, Herrick-Davis K, Emeson R, Sanders-Bush E: RNA editing silences serotonin 2C receptor constitutive activity. J Biol Chem 1999; 274: 9742-9751.
20. 2C receptor. Ann N Y Acad Sci 1998; 861: 38-48.
21. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB: Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997; 387: 303-308.
22. Gurevich I, Englander MT, Adlersberg M, Siegal NB, Schmauss C: Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J Neurosci 2002; 22: 10529-10532.
23. Bhansali P, Dunning J, Singer SE, David L, Schmauss C: Early life stress alters adult serotonin 2C receptor pre-mRNA editing and expression of the alpha subunit of the heterotrimeric G-protein Gq. J Neurosci 2007; 27: 1467-1473.
24. 2C receptor: alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 2001; 24: 478-491.
25. Sodhi MS, Burnet PW, Makoff AJ, Kerwin RW, Harrison PJ: RNA editing of the 5-HT 2C receptor is reduced in schizophrenia. Mol Psychiatry 2001; 6: 373-379.
26. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C: Altered editing of serotonin 2C receptor pre- mRNA in the prefrontal cortex of depressed suicide victims. Neuron 2002; 34: 349-356.
27. Kawahara Y, Sun H, Ito K, Hideyama T, Aoki M, Sobue G, Tsuji S, Kwak S: Underediting of GluR2 mRNA, a neuronal death inducing molecular change in sporadic ALS, does not occur in motor neurons in ALS1 or SBMA. Neurosci Res 2006; 54: 11-14.
28. Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S: Glutamate receptors: RNA editing and death of motor neurons. Nature 2004; 427: 801.
29. Paupard MC, O'Connell MA, Gerber AP, Zukin RS: Patterns of developmental expression of the RNA editing enzyme rADAR2. Neuroscience 2000; 95: 869-879.
30. Hartner JC, Schmittwolf C, Kispert A, Muller AM, Higuchi M, Seeburg PH: Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 2004; 279: 4894-4902.
31. Wang Q, Miyakoda M, Yang W, Khillan J, Stachura DL, Weiss MJ, Nishikura K: Stressinduced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 2004; 279: 4952-4961.
32. Lauder JM, Wilkie MB, Wu C, Singh S: Expression of 5-HT(2A), 5-HT(2B), and 5- HT(2C) receptors in the mouse embryo. Int J Dev Neurosci 2000;18:653-662.
33. Roth BL, Hamblin MW, Ciaranello RD: Developmental regulation of 5-HT2 and 5- HT1c mRNA and receptor levels. Brain Res Dev Brain Res 1991; 58: 51-58.
34. Agulnik AI, Mitchell MJ, Mattei MG, Borsani G, Avner PA, Lerner JL, Bishop CE: A novel X gene with a widely transcribed Ylinked homologue escapes X-inactivation in mouse and human. Hum Mol Genet 1994; 3: 879-884.
35. Jimenez A, Fernandez R, Madrid-Bury N, Moreira PN, Borque C, Pintado B, Gutierrez- Adan A: Experimental demonstration that pre- and post-conceptional mechanisms influence sex ratio in mouse embryos. Mol Reprod Dev 2003; 66: 162-165.
36. Stanwood GD, Parlaman JP, Levitt P: Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D 1 receptor mutant mice. J Comp Neurol 2005; 487: 270-282.
37. Stanwood GD, Washington RA, Levitt P: Identification of a sensitive period of prenatal cocaine exposure that alters the development of the anterior cingulate cortex. Cereb Cortex 2001; 11: 430-440.
38. George CX, Wagner MV, Samuel CE: Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing. J Biol Chem 2005; 280: 15020-15028.
39. Sansam CL, Wells KS, Emeson RB: Modulation of RNA editing by functional nucleolar sequestration of ADAR2. Proc Natl Acad Sci USA 2003; 100: 14018-14023.
40. 3 H]Dopa in various regions of the brain. J Neurochem 1966; 13: 655-669.
41. Sodhi MS, Airey DC, Lambert W, Burnet PW, Harrison PJ, Sanders-Bush E: A rapid new assay to detect RNA editing reveals antipsychotic- induced changes in serotonin- 2C transcripts. Mol Pharmacol 2005; 68: 711- 719.
42. Feng Y, Sansam CL, Singh M, Emeson RB: Altered RNA editing in mice lacking ADAR2 autoregulation. Mol Cell Biol 2006; 26: 480- 488.
43. 2C receptor. Neuropsychopharmacology 1999; 21: 82S- 90S.
44. Burnashev N, Monyer H, Seeburg PH, Sakmann B: Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 1992; 8: 189- 198.
45. Paschen W, Dux E, Djuricic B: Developmental changes in the extent of RNA editing of glutamate receptor subunit GluR5 in rat brain. Neurosci Lett 1994; 174: 109-112.
46. Wang Q, O'Brien PJ, Chen CX, Cho DS, Murray JM, Nishikura K: Altered G proteincoupling functions of RNA editing isoform and splicing variant serotonin 2C receptors. J Neurochem 2000; 74: 1290-1300.
47. Kawahara Y, Ito K, Sun H, Kanazawa I, Kwak S: Low editing efficiency of GluR2 mRNA is associated with a low relative abundance of ADAR2 mRNA in white matter of normal human brain. Eur J Neurosci 2003; 18: 23- 33.
48. Paschen W, Schmitt J, Gissel C, Dux E: Developmental changes of RNA editing of glutamate receptor subunits GluR5 and GluR6: in vivo versus in vitro. Brain Res Dev Brain Res 1997; 98: 271-280.
49. Melcher T, Maas S, Herb A, Sprengel R, Seeburg PH, Higuchi M: A mammalian RNA editing enzyme. Nature 1996; 379: 460-464.
50. Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N, Feldmeyer D, Sprengel R, Seeburg PH: Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 2000; 406: 78-81.
51. Dawson TR, Sansam CL, Emeson RB: Structure and sequence determinants required for the RNA editing of ADAR2 substrates. J Biol Chem 2004; 279: 4941-4951.
52. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 1995; 15: 193-204.
53. Melcher T, Maas S, Herb A, Sprengel R, Higuchi M, Seeburg PH: RED2, a brain-specific member of the RNA- specific adenosine deaminase family. J Biol Chem 1996; 271: 31795-31798.
54. Chen CX, Cho DS, Wang Q, Lai F, Carter KC, Nishikura K: A third member of the RNAspecific adenosine deaminase gene family, ADAR3, contains both single- and doublestranded RNA binding domains. RNA 2000; 6: 755-767.